OQROSign up free
Insider trade

Aquestive Therapeutics (AQST): CEO sold ~$2.4K

Daniel Barber, CEO at Aquestive Therapeutics, sold ~$2.4K of Aquestive Therapeutics shares.

~$2.4K
Approx. value · 400 sh @ $6.00
1.01M
Holds after · shares reported
Traded
Sep 19, 2025
Filed
Sep 22, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Sep 4, 2025InsiderOfficer sold ~$311K of AQST shares in the open market
  2. Sep 5, 2025InsiderOfficer sold ~$80K of AQST shares in the open market
  3. Sep 19, 2025 · this disclosureInsiderCEO sold ~$2.4K of AQST shares in the open market

What came next

  1. Sep 26, 2025Insider · 2 peopleInsiders: 2 sales (~$614K)
  2. Nov 5, 2025Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Aquestive Therapeutics

For Aquestive Therapeutics, OQRO holds 4 insider filings (SEC Form 4 or Form 144) and 2 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its AQST page.

Other recent filings by Daniel Barber, President and CEO

The full history of Daniel Barber, President and CEO is on the profile page.

How this filing works

Explore the data

Other disclosures at Aquestive Therapeutics

Everything OQRO holds on this company is on its AQST page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Sign up freeAlready have an account? Log in

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data